SEC CIK 1169896
HOBSON MELLODY L
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| SBUXview stock → | 445,533.75 | 2024-03-13 |
| GRPNview stock → | 63,706 | 2013-06-17 |
| JPMview stock → | 30,210.808 | 2026-09-30 |
| ELview stock → | 19,500 | 2017-08-29 |
Position History — JPM
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — JPM
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-30 | Grant / award | 136.022 | $330.83 | 30,210.808 |
| 2026-06-30 | Grant / award | 137.48 | $327.33 | 29,965.76 |
| 2026-03-31 | Grant / award | 152.98 | $294.16 | 29,704.98 |
| 2026-01-20 | Grant / award | 913.53 | $306.51 | 29,552.01 |
| 2025-12-31 | Grant / award | 139.66 | $322.22 | 28,534.86 |
| 2025-09-30 | Grant / award | 134.74 | $315.43 | 28,284.27 |
| 2025-06-30 | Grant / award | 155.22 | $289.91 | 28,042.53 |
| 2025-03-31 | Grant / award | 183.45 | $245.30 | 27,738.71 |
| 2025-01-21 | Grant / award | 1,011.93 | $261.88 | 27,555.26 |
| 2024-12-31 | Grant / award | 187.73 | $239.71 | 26,434.27 |
| 2024-09-30 | Grant / award | 237.12 | $210.86 | 26,124.01 |
| 2024-06-30 | Grant / award | 222.49 | $202.26 | 25,772.59 |
| 2024-03-29 | Grant / award | 249.63 | $200.30 | 25,433.53 |
| 2024-01-16 | Grant / award | 1,594.51 | $166.20 | 25,183.91 |
| 2023-12-31 | Grant / award | 253.77 | $170.10 | 23,479.31 |
| 2023-09-30 | Grant / award | 258.59 | $145.02 | 23,097.61 |
| 2023-06-30 | Grant / award | 257.84 | $145.44 | 22,718.23 |
| 2023-03-31 | Grant / award | 287.78 | $130.31 | 22,327.74 |
| 2023-01-19 | Open-market buy | 375 | $134.53 | 22,039.97 |
| 2023-01-17 | Grant / award | 1,780.85 | $140.38 | 21,664.97 |
| 2022-12-31 | Grant / award | 261 | $134.10 | 19,777.31 |
| 2022-09-30 | Grant / award | 334.93 | $104.50 | 19,383.71 |
| 2022-06-30 | Grant / award | 288.61 | $112.61 | 18,924.72 |
| 2022-03-31 | Grant / award | 238.41 | $136.32 | 18,533.53 |
| 2022-01-19 | Open-market buy | 670 | $149.68 | 18,295.12 |
| 2022-01-18 | Grant / award | 1,632.28 | $153.16 | 17,625.12 |
| 2021-12-31 | Grant / award | 221.03 | $158.35 | 15,923.06 |
| 2021-09-30 | Grant / award | 244.36 | $163.69 | 15,635.41 |
| 2021-06-30 | Grant / award | 241.1 | $155.54 | 15,326.79 |
| 2021-04-19 | Open-market buy | 660 | $153.12 | 15,085.69 |
| 2021-03-31 | Grant / award | 229.92 | $152.23 | 14,362.86 |
| 2021-01-19 | Grant / award | 1,795.2 | $139.26 | 14,074.35 |
| 2020-12-31 | Grant / award | 314.79 | $127.07 | 12,279.14 |
| 2020-09-30 | Grant / award | 441.47 | $96.27 | 11,889.29 |
| 2020-06-30 | Grant / award | 425.26 | $94.06 | 11,375.25 |
| 2020-03-31 | Grant / award | 499.83 | $90.03 | 10,877.91 |
| 2020-01-21 | Grant / award | 1,819.77 | $137.38 | 10,346.74 |
| 2020-01-15 | Open-market buy | 14,600 | $136.39 | 124,155 |
| 2019-12-31 | Grant / award | 340.75 | $139.40 | 8,526.97 |
| 2019-10-23 | Open-market buy | 16,000 | $124.65 | 109,555 |
| 2019-09-30 | Grant / award | 318.63 | $117.69 | 8,151.39 |
| 2019-08-08 | Open-market buy | 18,200 | $109.91 | 93,555 |
| 2019-06-30 | Grant / award | 290.7 | $111.80 | 7,803.92 |
| 2019-04-18 | Open-market buy | 1,700 | $114.26 | 7,484.58 |
| 2019-04-16 | Open-market buy | 18,000 | $111.02 | 75,355 |
| 2019-03-31 | Grant / award | 321.05 | $101.23 | 5,784.58 |
| 2019-01-15 | Grant / award | 2,486.7 | $100.54 | 5,455.94 |
| 2018-12-31 | Grant / award | 332.92 | $97.62 | 2,969.24 |
| 2018-10-19 | Open-market buy | 1,150 | $108.94 | 2,632.01 |
| 2018-09-30 | Grant / award | 288.02 | $112.84 | 1,482.01 |
| 2018-08-15 | Option exercise (derivative) | 46,308 | $0.00 | 0 |
| 2018-08-15 | Disposition to issuer | 16,953 | $113.70 | 57,355 |
| 2018-08-15 | Option exercise | 46,308 | $41.62 | 74,308 |
| 2018-06-30 | Grant / award | 328.22 | $104.20 | 1,192.22 |
| 2018-04-16 | Open-market buy | 18,000 | $111.05 | 28,000 |
| 2018-03-21 | — | — | — | 864 |
| 2018-03-21 | — | — | — | 10,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.